Insights

Regulatory Research PEI blends regulatory oversight with active biomedicine research, indicating opportunities to offer advanced data analytics, regulatory intelligence services, and collaboration on clinical trial design, pharmacovigilance workflows, and batch testing optimization.

Public Health Focus As Germany’s federal institute for vaccines and biomedicines, PEI is a strategic partner for vaccine development programs, immunology diagnostics, and safety evaluation initiatives, presenting avenues for joint R&D, trial advisory, and benchmarking of safety profiles.

Global Collaborations PEI supports WHO, EMA, and European Commission mandates and has recent CEPI collaboration, signaling a need for international project management, cross-border compliance solutions, and shared data platforms for regulatory-submission ecosystems.

Digital & Finance Stack With SAP FICO, DATEV, iCIMS, Microsoft Dynamics, and analytics tools in use, there is opportunity for ERP optimization services, HR and finance tech integration, and data-driven procurement or supplier management enhancements.

Growth & Outreach Growth in vaccine and biomedicine focus, coupled with a substantial employee base, suggests demand for workforce development, training programs, scientific advisory services, and pilot programs for new biomedicines and clinical trial workflows.

Similar companies to Paul-Ehrlich-Institut

Paul-Ehrlich-Institut Tech Stack

Paul-Ehrlich-Institut uses 8 technology products and services including SAP FICO, DATEV, iCIMS, and more. Explore Paul-Ehrlich-Institut's tech stack below.

Paul-Ehrlich-Institut's Email Address Formats

Paul-Ehrlich-Institut uses at least 4 email formats:
Paul-Ehrlich-Institut Email FormatsExamplePercentage
First.Last@pei.deJohn.Doe@pei.de
83%
Last.First@pei.deDoe.John@pei.de
8%
FLast@pei.deJDoe@pei.de
6%
First_Last@pei.deJohn_Doe@pei.de
3%

Frequently Asked Questions

What is Paul-Ehrlich-Institut's official website and social media links?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's official website is pei.de and has social profiles on LinkedIn.

How much revenue does Paul-Ehrlich-Institut generate?

Minus sign iconPlus sign icon
As of August 2026, Paul-Ehrlich-Institut's annual revenue is estimated to be $25M - $50M.

What is Paul-Ehrlich-Institut's NAICS code?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Paul-Ehrlich-Institut have currently?

Minus sign iconPlus sign icon
As of August 2026, Paul-Ehrlich-Institut has approximately 470 employees across 2 continents, including Europe and North America. Key team members include President: S. V., Head Of Media And Public Relations: C. L. and Head Of Unit: Safety Of Veterinary Immunological Products: R. W. Explore Paul-Ehrlich-Institut's employee directory with LeadIQ.

What industry does Paul-Ehrlich-Institut belong to?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut operates in the Research Services industry.

What technology does Paul-Ehrlich-Institut use?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's tech stack includes SAP FICO, DATEV, iCIMS, Microsoft Dynamics, Microsoft, Piwik, Microsoft Teams and Piwik PRO Core.

What is Paul-Ehrlich-Institut's email format?

Minus sign iconPlus sign icon
Paul-Ehrlich-Institut's email format typically follows the pattern of First.Last@pei.de. Find more Paul-Ehrlich-Institut email formats with LeadIQ.
Paul-Ehrlich-Institut logo

Paul-Ehrlich-Institut

Research ServicesHesse, Germany201-500 Employees

The Paul-Ehrlich-Institut is Germany’s Federal Institute for Vaccines and Biomedicines, combining regulatory responsibilities with active biomedical research. Based near Frankfurt in Langen, it operates under the Federal Ministry of Health and conducts research on biomedicines for humans and veterinary immunological products while also granting authorisations when benefits outweigh risks. The institute oversees clinical trial approvals, pharmacovigilance, official batch testing, scientific advice, and inspections, supporting public health through rigorous evaluation and monitoring of medicinal products. In addition to its regulatory duties, it engages in independent experimental research that informs and underpins its regulatory activities, aiming to improve access to safe, effective, and high-quality biomedicines. The organization collaborates with international bodies and contributes expert guidance to entities such as the WHO, EMA, and the European Commission, reflecting its dual role in science and regulation. A recent collaboration highlighted its ongoing international engagement, exemplified by partnerships and joint projects with global health organizations. The institute employs staff across its research and regulatory functions, reflecting its broad scope and public health mandate. } ) } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

Website
pei.de
NAICS Code
5417 - Scientific Research and Development Services
Employees
201-500

Section iconFunding & Financials

  • $25M - $50M

    Paul-Ehrlich-Institut's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.